{"title":"痴呆患者的犯罪心理:系统综述和定量荟萃分析。","authors":"Matthias L Schroeter, Marija Žuvela, Lena Szabo","doi":"10.1038/s41398-025-03523-z","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Subjects with dementia might exhibit criminal risk behavior (CB), even in early disease stages.</p><p><strong>Methods: </strong>This systematic review and quantitative meta-analysis investigated CB prevalence across all neurodegenerative syndromes according to PRISMA criteria and preregistered in PROSPERO. Mean frequencies and odds ratios were calculated and compared.</p><p><strong>Results: </strong>Finally, the meta-analysis included 14 studies with 236,360 persons. Studies originated from different countries, with largest contributing country being the U.S.A., followed by Scandinavian countries, i.e., Sweden and Finland, and additionally Germany and Japan. All quantitative analyses revealed a very consistent picture: CB prevalence was highest in behavioral variant frontotemporal dementia ( >50%), followed by semantic variant primary progressive aphasia (40%), but rather low in vascular dementia and Huntington's disease (15%), Alzheimer's disease (10%), lowest in Parkinsonian syndromes ( <10%). The systematic literature review revealed that CB prevalence is more frequent in early disease course than in the general population, but declines thereafter below population levels. Men are overrepresented.</p><p><strong>Discussion: </strong>CB is a common symptom in dementia, most pronounced in frontotemporal dementia. CB committed for the first time at mid-age could be an indicator of incident dementia, requiring earliest diagnosis and therapy. As present studies show a wide variability in assessment methods and cohorts investigated, and had been conducted in a minority of countries world-wide, large prospective international studies are warranted that systematically apply homogeneous methods and standardized questionnaires in assessing criminal risk behavior in different dementia syndromes.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"324"},"PeriodicalIF":6.2000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394586/pdf/","citationCount":"0","resultStr":"{\"title\":\"Criminal minds in dementia: A systematic review and quantitative meta-analysis.\",\"authors\":\"Matthias L Schroeter, Marija Žuvela, Lena Szabo\",\"doi\":\"10.1038/s41398-025-03523-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Subjects with dementia might exhibit criminal risk behavior (CB), even in early disease stages.</p><p><strong>Methods: </strong>This systematic review and quantitative meta-analysis investigated CB prevalence across all neurodegenerative syndromes according to PRISMA criteria and preregistered in PROSPERO. Mean frequencies and odds ratios were calculated and compared.</p><p><strong>Results: </strong>Finally, the meta-analysis included 14 studies with 236,360 persons. Studies originated from different countries, with largest contributing country being the U.S.A., followed by Scandinavian countries, i.e., Sweden and Finland, and additionally Germany and Japan. All quantitative analyses revealed a very consistent picture: CB prevalence was highest in behavioral variant frontotemporal dementia ( >50%), followed by semantic variant primary progressive aphasia (40%), but rather low in vascular dementia and Huntington's disease (15%), Alzheimer's disease (10%), lowest in Parkinsonian syndromes ( <10%). The systematic literature review revealed that CB prevalence is more frequent in early disease course than in the general population, but declines thereafter below population levels. Men are overrepresented.</p><p><strong>Discussion: </strong>CB is a common symptom in dementia, most pronounced in frontotemporal dementia. CB committed for the first time at mid-age could be an indicator of incident dementia, requiring earliest diagnosis and therapy. As present studies show a wide variability in assessment methods and cohorts investigated, and had been conducted in a minority of countries world-wide, large prospective international studies are warranted that systematically apply homogeneous methods and standardized questionnaires in assessing criminal risk behavior in different dementia syndromes.</p>\",\"PeriodicalId\":23278,\"journal\":{\"name\":\"Translational Psychiatry\",\"volume\":\"15 1\",\"pages\":\"324\"},\"PeriodicalIF\":6.2000,\"publicationDate\":\"2025-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394586/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41398-025-03523-z\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03523-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
Criminal minds in dementia: A systematic review and quantitative meta-analysis.
Introduction: Subjects with dementia might exhibit criminal risk behavior (CB), even in early disease stages.
Methods: This systematic review and quantitative meta-analysis investigated CB prevalence across all neurodegenerative syndromes according to PRISMA criteria and preregistered in PROSPERO. Mean frequencies and odds ratios were calculated and compared.
Results: Finally, the meta-analysis included 14 studies with 236,360 persons. Studies originated from different countries, with largest contributing country being the U.S.A., followed by Scandinavian countries, i.e., Sweden and Finland, and additionally Germany and Japan. All quantitative analyses revealed a very consistent picture: CB prevalence was highest in behavioral variant frontotemporal dementia ( >50%), followed by semantic variant primary progressive aphasia (40%), but rather low in vascular dementia and Huntington's disease (15%), Alzheimer's disease (10%), lowest in Parkinsonian syndromes ( <10%). The systematic literature review revealed that CB prevalence is more frequent in early disease course than in the general population, but declines thereafter below population levels. Men are overrepresented.
Discussion: CB is a common symptom in dementia, most pronounced in frontotemporal dementia. CB committed for the first time at mid-age could be an indicator of incident dementia, requiring earliest diagnosis and therapy. As present studies show a wide variability in assessment methods and cohorts investigated, and had been conducted in a minority of countries world-wide, large prospective international studies are warranted that systematically apply homogeneous methods and standardized questionnaires in assessing criminal risk behavior in different dementia syndromes.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.